May 26, 2020
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
May 19, 2020
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy(TM) (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
May 07, 2020
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 30, 2020
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
Apr 27, 2020
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
Apr 01, 2020
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
Mar 23, 2020
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Mar 13, 2020
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Jan 07, 2020
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
Jan 06, 2020
Eiger Updates on 2019 Progress and 2020 Milestones Expected
Dec 17, 2019
First-Ever Treatment for Rare, Rapid-Aging Disease Progeria Submitted in New Drug Application to the FDA
Dec 16, 2019
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Aug 08, 2019
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
Jun 17, 2019
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)
Jun 10, 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
Jun 05, 2019
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
May 17, 2019
Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
May 09, 2019
Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
Apr 30, 2019
Eiger to Present at ChinaBio® Partnering Forum 2019
Mar 26, 2019
Eiger BioPharmaceuticals to Participate in Conferences in April